Preclinical Evaluation of Tumor Microvascular Response to a Novel Antiangiogenic/Antitumor Agent RO0281501 by Dynamic Contrast-Enhanced MRI at 1.5 T

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)